semaglutide nih In a recent study conducted by and @cwru, was associated with lower risk of suicidal ideations compared to other treatments prescribed for obesity or type 2 diabetes. Click the link in Semaglutide: Double-edged Sword with Risks

The key factor is the quality of the compounding pharmacy, which brings us to a concern about Maximus that we will address in the transparency section below

GLP-1 decreases inflammation in pancreas which can help in preserving beta cells and ameliorate the progression to Type 1 diabetes

When doses increase too quickly, the digestive system has less time to adapt, which can intensify symptoms

Compounded semaglutide is the same active pharmaceutical ingredient as Ozempic and Wegovy, but it is prepared by 503A or 503B compounding pharmacies under FDA compounding regulations rather than being manufactured by Novo Nordisk